NYSE:CPTCamden Property Trust Stock Price, Forecast & News

Camden Property Trust's stock was trading at $95.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CPT stock has decreased by 2.1% and is now trading at $93.31. View which stocks have been most impacted by Coronavirus.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Camden Property Trust in the last year. There are currently 5 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Camden Property Trust.

Camden Property Trust is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Camden Property Trust.

Camden Property Trust (NYSE:CPT) released its earnings results on Thursday, May, 7th. The real estate investment trust reported $0.43 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.31 by $0.88. The real estate investment trust earned $266 million during the quarter, compared to analysts' expectations of $265.34 million. Camden Property Trust had a net margin of 21.45% and a return on equity of 6.10%. The business's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the business earned $1.22 EPS. View Camden Property Trust's earnings history.

Camden Property Trust announced a quarterly dividend on Thursday, January 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.80 per share on Friday, April 17th. This represents a $3.20 annualized dividend and a dividend yield of 3.43%. The ex-dividend date is Monday, March 30th. View Camden Property Trust's dividend history.

19 Wall Street analysts have issued twelve-month target prices for Camden Property Trust's shares. Their forecasts range from $80.00 to $124.00. On average, they anticipate Camden Property Trust's stock price to reach $108.88 in the next year. This suggests a possible upside of 16.7% from the stock's current price. View analysts' price targets for Camden Property Trust.

News headlines about CPT stock have trended positive this week, InfoTrie reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Camden Property Trust earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave media stories about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutCamden Property Trust.

Some companies that are related to Camden Property Trust include Equity Residential (EQR), AvalonBay Communities (AVB), Essex Property Trust (ESS), Mid-America Apartment Communities (MAA), Sun Communities (SUI), Equity Lifestyle Properties (ELS), UDR (UDR), Apartment Investment and Management (AIV), American Campus Communities (ACC) and UMH PROPERTIES/SH SH (UMH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Camden Property Trust investors own include Amgen (AMGN), Cisco Systems (CSCO), Gilead Sciences (GILD), Nike (NKE), NVIDIA (NVDA), Procter & Gamble (PG), Quest Diagnostics (DGX), Walt Disney (DIS), JPMorgan Chase & Co. (JPM) and Lockheed Martin (LMT).

Camden Property Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CPT."

Camden Property Trust's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.49%), State Street Corp (5.71%), Capital World Investors (2.65%), Nuveen Asset Management LLC (1.72%), Geode Capital Management LLC (1.67%) and Thrivent Financial for Lutherans (1.44%). Company insiders that own Camden Property Trust stock include Alexander J Jessett, D Keith Oden, H Malcolm Stewart, Michael P Gallagher, Richard J Campo, Scott S Ingraham, William B Mcguire, William F Paulsen and William W Sengelmann. View institutional ownership trends for Camden Property Trust.

CPT stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Balyasny Asset Management LLC, Wellington Management Group LLP, Nuveen Asset Management LLC, BlackRock Inc., Resolution Capital Ltd, Cbre Clarion Securities LLC, and Raymond James & Associates. Company insiders that have sold Camden Property Trust company stock in the last year include D Keith Oden, H Malcolm Stewart, Richard J Campo, Scott S Ingraham, William B Mcguire, and William W Sengelmann. View insider buying and selling activity for Camden Property Trust.

CPT stock was acquired by a variety of institutional investors in the last quarter, including Capital World Investors, Sumitomo Mitsui Trust Holdings Inc., First Trust Advisors LP, JPMorgan Chase & Co., V3 Capital Management L.P., Janus Henderson Group PLC, Centersquare Investment Management LLC, and Presima Inc.. View insider buying and selling activity for Camden Property Trust.

Shares of CPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CPT stock can currently be purchased for approximately $93.31.

Camden Property Trust has a market capitalization of $9.09 billion and generates $1.03 billion in revenue each year. The real estate investment trust earns $219.62 million in net income (profit) each year or $5.04 on an earnings per share basis. Camden Property Trust employs 1,650 workers across the globe.

The official website for Camden Property Trust is www.camdenliving.com.

Camden Property Trust's mailing address is 11 Greenway Plaza Suite 2400, Houston TX, 77046. The real estate investment trust can be reached via phone at 713-354-2500 or via email at [email protected]